Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - Feasibility and clinical response

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Habermehl, Daniel ^a   Debus, Jürgen ^a   Ganten, Tom ^a   Ganten, Maria Katharina ^b   Bauer, Julia ^a   Brecht, Ingo C ^a   Brons, Stephan ^a   Haberer, Thomas ^a   Haertig, Martin ^a   Jäkel, Oliver ^a   Parodi, Katia ^a   Welzel, Thomas ^a   Combs, Stephanie E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SORAFENIB;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TARGET VOLUME; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOFRACTIONATED RADIOTHERAPY; IN VIVO STUDY; ION THERAPY; IRRADIATION; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; RADIATION BEAM; RADIATION DOSE; RADIATION RESPONSE; RADIATION TOLERANCE; RELATIVE BIOLOGIC EFFECTIVENESS; TIME TO TREATMENT; TREATMENT RESPONSE; CLINICAL TRIAL; LIVER TUMOR; METHODOLOGY; RADIATION DOSE FRACTIONATION; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS;

AGED; CARCINOMA, HEPATOCELLULAR; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; HEAVY ION RADIOTHERAPY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 84874796373     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717x-8-59     Document Type: Article

References (18)

1. Llovet JM, Ricci S, Mazzaferro V, et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008, 359:378-390
2. Komatsu S, Fukumoto T, Demizu Y, et al: Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma. Cancer 2011, 117:4890-4904
3. Dawson LA, Ten Haken RK: Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 2005, 15:279-283
4. Jianshe Y, Wenjian L, Xiaodong J, et al: Survival and initial chromatid breakage in normal and tumour cells exposed in vitro to gamma rays and carbon ions at the HIRFL. Br J Radiol 2006, 79:518-521
5. Tan CH, Low SC, Thng CH: APASL and AASLD consensus guidelines on imaging diagnosis of hepatocellular carcinoma: a review. Int J Hepatol 2011, 2011:519783
6. Herfarth KK, Debus J, Lohr F, et al: Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases. Int J Radiat Oncol Biol Phys 2000, 46:329-335
7. Pan CC, Kavanagh BD, Dawson LA, et al: Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 2010, 76:S94-S100
8. Elsasser T, Weyrather WK, Friedrich T, et al: Quantification of the relative biological effectiveness for ion beam radiotherapy: direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning. Int J Radiat Oncol Biol Phys 2010, 78:1177-1183
9. Llovet JM, Di Bisceglie AM, Bruix J, et al: Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Canc Inst 2008, 100:698-711
10. Kato H, Tsujii H, Miyamoto T, et al: Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 2004, 59:1468-1476
11. Imada H, Kato H, Yasuda S, et al: Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis. Radiother Oncol 2010, 96:231-235
12. Bush DA, Kayali Z, Grove R, et al: The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial. Cancer 2011, 117:3053-3059
13. Kawashima M, Furuse J, Nishio T, et al: Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol 2005, 23:1839-1846
14. Skinner HD, Sharp HJ, Kaseb AO, et al: Radiation treatment outcomes for unresectable hepatocellular carcinoma. Acta Oncol 2011, 50:1191-1198
15. Herfarth KK, Hof H, Bahner ML, et al: Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 2003, 57:444-451
16. Olsen CC, Welsh J, Kavanagh BD, et al: Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2009, 73:1414-1424
17. Mizumoto M, Okumura T, Hashimoto T, et al: Evaluation of liver function after proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2012, 82:e529-e535
18. Rietzel E, Bert C: Respiratory motion management in particle therapy. Med Phys 2010, 37:449-460